Inscripta is a life science technology company whose mission is to empower researchers to realize the full potential of the bioeconomy. Inscripta has developed the world’s first benchtop system for scalable digital genome engineering and consists of a benchtop instrument, consumables, software and assays. With a fully automated CRISPR-based workflow, the Onyx platform enables massively parallel, trackable editing of single cells at an unprecedented scale. The company is headquartered in Boulder, Colo., with offices in San Diego and Pleasanton, Calif., and Copenhagen, Denmark.
Inscripta
5500 Central Avenue, #220
Boulder, CO 80301